Riesgo de recurrencia tras retirada de la anticoagulación en pacientes con enfermedad tromboembólica venosa no provocada: validación externa del nomograma de Viena y del modelo predictivo DASH
- 1 December 2019
- journal article
- research article
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 55 (12) , 619-626
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- External validation of a Cox prognostic model: principles and methodsBMC Medical Research Methodology, 2013
- Management of Patients With Unprovoked Venous Thromboembolism: An Evidence-Based and Practical ApproachCurrent Treatment Options in Cardiovascular Medicine, 2013
- Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolismThrombosis and Haemostasis, 2013
- Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)Journal of Thrombosis and Haemostasis, 2012
- Antithrombotic Therapy for VTE DiseaseChest, 2012
- Risk assessment for recurrent venous thrombosisThe Lancet, 2010
- Diagnosis of venous thromboembolism: an updateVascular Medicine, 2010
- Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reportingJournal of Thrombosis and Haemostasis, 2010
- Systematic Review: Case-Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding Events Among Patients Treated for Venous ThromboembolismAnnals of Internal Medicine, 2010
- Incidence and mortality of venous thrombosis: a population‐based studyJournal of Thrombosis and Haemostasis, 2007